The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Correction re Share Transfer

17 Aug 2010 15:42

RNS Number : 2200R
Phorm Inc
17 August 2010
 



17th August 2010

 

 

Phorm, Inc. ("Phorm" or the "Company")

 

Correction: Number of Shares in Reg S Line (PHRM) and Unrestricted Line (PHRX)

 

Phorm, Inc., (AIM: PHRX and PHRM), today announces a correction to the number of shares outstanding in the Reg S Line (PHRM and the Unrestricted Line (PHRX), subsequent to a previously announced transfer of shares on 16 August 2010 with RNS Number 1494R.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

16 August 2010

 

 

Phorm, Inc. ("Phorm" or the "Company")

 

Transfer of Shares between Reg S Line (PHRM) and Unrestricted Line (PHRX)

 

Phorm, Inc., (AIM: PHRX and PHRM), today announces that the Company has applied to AIM for the following shares to be transferred from the unrestricted line, trading under PHRX, to the restricted line, trading under PHRM, and from the restricted line, trading under PHRM to the unrestricted line, trading under PHRX.

 

The transfers are expected to take effect from 20 August 2010.

 

Description of Security Old Ticker Symbol New Ticker Symbol No. of Shares

----------------------------- ------------------------ ------------------------- -----------------

 

Common Shares of

$0.001 each PHRM PHRX 315,291

 

Common Shares of

$0.001 each PHRX PHRM 104,000

 

 Following the transfer of these shares the Company still has a total of 18,479,907 issued and outstanding Common Shares trading on AIM, of which 17,472,014 will be in the restricted line, trading under PHRM, and 1,007,893 in the unrestricted line, trading under PHRX. 45,000 of the aforementioned PHRM Common Shares are held in treasury.

 

No new shares have been issued and, as previously indicated, dealings in the shares under the new ticker symbols are expected to commence on 20 August 2010.

 

 

For Enquiries

Phorm, Inc. +44 20 7297 2433

Sarah Simon

 

Citigate Dewe Rogerson +44 20 7638 9571

Simon Rigby

Justin Griffiths

 

Canaccord Genuity Limited +44 20 7050 6500

Mark Williams

Andrew Chubb

 

- ends -

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFMGMRDNVGGZM

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.